share

Thiazolo[3,2-B][2,4]Benzodiazepine, 5,10-Dihydro-3-Methyl- (8Ci) CAS NO 802864-14-8


Unit Price:

CAS No.:802864-14-8

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Thiazolo[3,2-B][2,4]Benzodiazepine, 5,10-Dihydro-3-Methyl- (8Ci) is a high-purity, specialized heterocyclic organic compound identified by CAS number 802864-14-8. This compound serves as a critical advanced intermediate in pharmaceutical research and development, particularly for synthesizing novel therapeutic agents. It is essential for R&D chemists and process development scientists working in medicinal chemistry, agrochemical discovery, and advanced material science.

Application

  • Pharmaceutical Intermediate: A key building block for the synthesis of novel benzodiazepine and thiazole-fused heterocyclic compounds with potential biological activity.
  • Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for discovering new central nervous system (CNS) or other therapeutic agents.
  • Agrochemical Development: Serves as a precursor in the research and synthesis of new crop protection agents and pesticides.
  • Chemical Biology Probes: Utilized in the development of molecular probes to study biological pathways and protein interactions.
  • Academic & Institutional R&D: Employed in university and research institute laboratories for fundamental studies in organic synthesis and heterocyclic chemistry.
  • Custom Synthesis & Contract Manufacturing: A starting material for custom synthesis projects and scale-up processes under cGMP or research-grade conditions.

Basic Information

Product Name Thiazolo[3,2-B][2,4]Benzodiazepine, 5,10-Dihydro-3-Methyl- (8Ci)
CAS No. 802864-14-8
Molecular Formula C12H10N2S
Molecular Weight 214.29 g/mol
Synonyms 5,10-Dihydro-3-methylthiazolo[3,2-b][1,4]benzodiazepine; 3-Methyl-5,10-dihydrothiazolo[3,2-b][1,4]benzodiazepine; Thiazolo[3,2-b][1,4]benzodiazepine, 5,10-dihydro-3-methyl-; 802864-14-8; Thiazolobenzodiazepine derivative; 3-Methyl-dihydro-thiazolobenzodiazepine
EINECS Contact for details

Quality Control

Our Thiazolo[3,2-B][2,4]Benzodiazepine, 5,10-Dihydro-3-Methyl- (8Ci) is produced under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS), to ensure it meets the stringent requirements of research and development applications. Certificates of Analysis (COA) with detailed specifications are provided for every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider storage under an inert atmosphere.

Specification

Item Specification
Appearance Off-white to light yellow crystalline powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference standard
Purity (HPLC) ≥ 97.0%
Related Substances (HPLC) Total impurities ≤ 3.0%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.